HighTower Advisors, LLC - SECOND SIGHT MED PRODS INC ownership

SECOND SIGHT MED PRODS INC's ticker is EYESXXXX and the CUSIP is 81362J100. A total of 43 filers reported holding SECOND SIGHT MED PRODS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
HighTower Advisors, LLC ownership history of SECOND SIGHT MED PRODS INC
ValueSharesWeighting
Q3 2019$24,000
+4.3%
29,2000.0%0.00%
Q2 2019$23,0000.0%29,2000.0%0.00%
Q1 2019$23,000
-11.5%
29,2000.0%0.00%
Q4 2018$26,000
-52.7%
29,2000.0%0.00%
Q3 2018$55,00029,2000.00%
Other shareholders
SECOND SIGHT MED PRODS INC shareholders Q4 2018
NameSharesValueWeighting ↓
ORACLE INVESTMENT MANAGEMENT INC 431,582$4,428,0000.58%
AWM Investment Company, Inc. 234,965$2,411,0000.33%
DAFNA Capital Management LLC 39,800$408,0000.32%
AYM CAPITAL, LLC 15,193$156,0000.12%
CARL DOMINO INC 20,350$209,0000.11%
JW Asset Management, LLC 8,500$87,0000.06%
NumerixS Investment Technologies Inc 13,800$142,0000.05%
FIDUCIARY TRUST INTERNATIONAL LLC 14,100$145,0000.04%
Cubist Systematic Strategies, LLC 15,711$161,0000.01%
REGIONS FINANCIAL CORP 32,000$328,0000.00%
View complete list of SECOND SIGHT MED PRODS INC shareholders